New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis

Overview

Journal Cell Rep

Publisher Cell Press

Specialties Biology
Cell Biology
Molecular Biology

Date 2015 Oct 23

PMID 26489459

Citations 56

Authors

Florian Rambow

Bastien Job

Valerie Petit

Franck Gesbert

Veronique Delmas

Hannah Seberg

Guillaume Meurice

Eric Van Otterloo

Philippe Dessen

Caroline Robert

Daniel Gautheret

Robert A Cornell

Alain Sarasin

Lionel Larue

Affiliations

Soon will be listed here.

Abstract

Molecular signatures specific to particular tumor types are required to design treatments for resistant tumors. However, it remains unclear whether tumors and corresponding cell lines used for drug development share such signatures. We developed similarity core analysis (SCA), a universal and unsupervised computational framework for extracting core molecular features common to tumors and cell lines. We applied SCA to mRNA/miRNA expression data from various sources, comparing melanoma cell lines and metastases. The signature obtained was associated with phenotypic characteristics in vitro, and the core genes CAPN3 and TRIM63 were implicated in melanoma cell migration/invasion. About 90% of the melanoma signature genes belong to an intrinsic network of transcription factors governing neural development (TFAP2A, DLX2, ALX1, MITF, PAX3, SOX10, LEF1, and GAS7) and miRNAs (211-5p, 221-3p, and 10a-5p). The SCA signature effectively discriminated between two subpopulations of melanoma patients differing in overall survival, and classified MEKi/BRAFi-resistant and -sensitive melanoma cell lines.

Citing Articles

Keratin intermediate filaments mechanically position melanin pigments for genome photoprotection.

Benito-Martinez S, Salavessa L, Mace A, Lardier N, Fraisier V, Sires-Campos J bioRxiv. 2025; .

PMID: 39868182 PMC: 11761041. DOI: 10.1101/2025.01.15.632531.

Leveraging gene correlations in single cell transcriptomic data.

Silkwood K, Dollinger E, Gervin J, Atwood S, Nie Q, Lander A BMC Bioinformatics. 2024; 25(1):305.

PMID: 39294560 PMC: 11411778. DOI: 10.1186/s12859-024-05926-z.

New Insights into the Exosome-Induced Migration of Uveal Melanoma Cells and the Pre-Metastatic Niche Formation in the Liver.

Ramos R, Vinyals A, Campos-Martin R, Cabre E, Bech J, Vaquero J Cancers (Basel). 2024; 16(17).

PMID: 39272836 PMC: 11394004. DOI: 10.3390/cancers16172977.

What Makes a Mimic? Orange, Red, and Black Color Production in the Mimic Poison Frog (Ranitomeya imitator).

Rubio A, Stuckert A, Geralds B, Nielsen R, MacManes M, Summers K Genome Biol Evol. 2024; 16(7).

PMID: 38874406 PMC: 11255871. DOI: 10.1093/gbe/evae123.

Advances and challenges in modeling inherited peripheral neuropathies using iPSCs.

Van Lent J, Prior R, Perez Siles G, Cutrupi A, Kennerson M, Vangansewinkel T Exp Mol Med. 2024; 56(6):1348-1364.

PMID: 38825644 PMC: 11263568. DOI: 10.1038/s12276-024-01250-x.

References

Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek K . Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 2006; 20(24):3426-39. PMC: 1698449. DOI: 10.1101/gad.406406. View

Koludrovic D, Davidson I . MITF, the Janus transcription factor of melanoma. Future Oncol. 2013; 9(2):235-44. DOI: 10.2217/fon.12.177. View

Dancik G, Ru Y, Owens C, Theodorescu D . A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers. Cancer Res. 2011; 71(24):7398-409. PMC: 3242880. DOI: 10.1158/0008-5472.CAN-11-2427. View

Harris M, Baxter L, Loftus S, Pavan W . Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res. 2010; 23(4):496-513. PMC: 2906668. DOI: 10.1111/j.1755-148X.2010.00711.x. View

Gonzalez-Angulo A, Hennessy B, Mills G . Future of personalized medicine in oncology: a systems biology approach. J Clin Oncol. 2010; 28(16):2777-83. PMC: 2881854. DOI: 10.1200/JCO.2009.27.0777. View

Cheli Y, Giuliano S, Guiliano S, Botton T, Rocchi S, Hofman V . Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene. 2011; 30(20):2307-18. DOI: 10.1038/onc.2010.598. View

Daniele T, Hurbain I, Vago R, Casari G, Raposo G, Tacchetti C . Mitochondria and melanosomes establish physical contacts modulated by Mfn2 and involved in organelle biogenesis. Curr Biol. 2014; 24(4):393-403. DOI: 10.1016/j.cub.2014.01.007. View

Hoek K, Schlegel N, Brafford P, Sucker A, Ugurel S, Kumar R . Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 2006; 19(4):290-302. DOI: 10.1111/j.1600-0749.2006.00322.x. View

Masters J . Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol. 2001; 1(3):233-6. DOI: 10.1038/35043102. View

10.

Kanemaru H, Fukushima S, Yamashita J, Honda N, Oyama R, Kakimoto A . The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci. 2011; 61(3):187-93. DOI: 10.1016/j.jdermsci.2010.12.010. View

11.

Cheli Y, Ohanna M, Ballotti R, Bertolotto C . Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell Melanoma Res. 2009; 23(1):27-40. DOI: 10.1111/j.1755-148X.2009.00653.x. View

12.

Cheung H, Cowley G, Weir B, Boehm J, Rusin S, Scott J . Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc Natl Acad Sci U S A. 2011; 108(30):12372-7. PMC: 3145679. DOI: 10.1073/pnas.1109363108. View

13.

Mann G, Pupo G, Campain A, Carter C, Schramm S, Pianova S . BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma. J Invest Dermatol. 2012; 133(2):509-17. DOI: 10.1038/jid.2012.283. View

14.

Uva P, Lahm A, Sbardellati A, Grigoriadis A, Tutt A, de Rinaldis E . Comparative Membranome expression analysis in primary tumors and derived cell lines. PLoS One. 2010; 5(7):e11742. PMC: 2909215. DOI: 10.1371/journal.pone.0011742. View

15.

Alonso-Curbelo D, Riveiro-Falkenbach E, Perez-Guijarro E, Cifdaloz M, Karras P, Osterloh L . RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. Cancer Cell. 2014; 26(1):61-76. DOI: 10.1016/j.ccr.2014.04.030. View

16.

Betancur P, Bronner-Fraser M, Sauka-Spengler T . Genomic code for Sox10 activation reveals a key regulatory enhancer for cranial neural crest. Proc Natl Acad Sci U S A. 2010; 107(8):3570-5. PMC: 2840498. DOI: 10.1073/pnas.0906596107. View

17.

Merlo G, Zerega B, Paleari L, Trombino S, Mantero S, Levi G . Multiple functions of Dlx genes. Int J Dev Biol. 2000; 44(6):619-26. View

18.

Medic S, Ziman M . PAX3 across the spectrum: from melanoblast to melanoma. Crit Rev Biochem Mol Biol. 2009; 44(2-3):85-97. DOI: 10.1080/10409230902755056. View

19.

Juriloff D, Harris M . Mouse models for neural tube closure defects. Hum Mol Genet. 2000; 9(6):993-1000. DOI: 10.1093/hmg/9.6.993. View

20.

Segura M, Belitskaya-Levy I, Rose A, Zakrzewski J, Gaziel A, Hanniford D . Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res. 2010; 16(5):1577-86. PMC: 4662869. DOI: 10.1158/1078-0432.CCR-09-2721. View